Device Authority partnership expands route into enterprise IoT security

Tern plc

Device Authority has strengthened its enterprise market positioning through a strategic partnership with Xalient, bringing its KeyScaler platform into a managed cybersecurity model focused on identity-led protection for IoT and OT environments.

Enterprises are continuing to expand connected device estates across operational settings, where unmanaged assets, long device lifecycles and fragmented security processes can increase exposure to cyber risk. As these environments become more complex, demand is shifting towards automated tools that can manage device identity, access and compliance at scale.

The partnership gives Xalient the ability to integrate Device Authority’s KeyScaler technology into its IoT security offering. This is intended to help enterprise customers protect connected devices across complex environments by automating key parts of the device identity lifecycle. These include secure onboarding, credential provisioning, certificate rotation, decommissioning and policy-driven access control.

The collaboration also reflects the growing importance of Zero Trust-aligned security models. Rather than relying on static perimeter defences, enterprises need ways to verify and manage users, devices, workloads and machine identities continuously. KeyScaler is designed for IoT and OT environments, where traditional IT security tools may not be sufficient and where automation can help reduce the burden on internal teams.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Breast cancer research highlights importance of patient intelligence in pharma

Talking Medicines highlights how AI-powered patient intelligence can help pharmaceutical companies understand breast cancer treatment experiences and identify unmet...

GLP-1 drugs linked to emerging research into mental health and addiction

Research into GLP-1 medicines is expanding beyond weight loss, with studies examining potential links to depression, cognitive function, alcohol...

Talking Medicines examines emerging links between GLP-1 drugs and mental health

Researchers are investigating the potential links between GLP-1 medicines and mental health, with early findings prompting further studies into...

Tern invests £78,000 in Device Authority through 8% convertible loan notes

Tern Plc has committed approximately £78,000 to new convertible loan notes issued by Device Authority, which carry 8% annual...

Device Authority highlights security risks as AI begins controlling physical machines

Device Authority examines the security risks of AI-controlled machinery and the role of device identity, authentication and access controls...

Talking Medicines targets better pharmaceutical launch results through message analysis

Talking Medicines' Message Resonance Score measures doctors' understanding of pharmaceutical messaging to help companies improve launch strategies....

Search